Xinbang Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 41.2442 million yuan, a decrease of 29.89%

Xinbang Pharmaceutical released its Q1 2025 performance, with operating revenue of 1.441 billion yuan, a year-on-year decrease of 8.93%; net profit attributable to the parent company of 41.2442 million yuan, a year-on-year decline of 29.89%; net profit excluding non-recurring gains and losses of 41.0754 million yuan, a year-on-year decrease of 30.16%; basic earnings per share of 0.02 yuan